Clarithromycin Linked to Increased Cardiac Death Risk

(HealthDay News) -- There is a significantly increased risk of cardiac death associated with clarithromycin use, according to a study published online August 19 in BMJ.

Henrik Svanström, from the Statens Serum Institut in Copenhagen, Denmark, and colleagues assessed the risk of cardiac death associated with use of clarithromycin and roxithromycin compared with penicillin V in Danish adults (aged 40–74 years). Participants had received seven-day treatment courses with clarithromycin (160,297 adults), roxithromycin (588,988 adults), and penicillin V (4,355,309 adults).

Here is the source article:

http://www.empr.com/clarithromycin-linked-to-increased-cardiac-death-risk/article/367195/?DCMP=EMC-MPR_DailyDose&CPN&spMailingID=9273670&spUserID=NTc2NzQzMDc4NTkS1&spJobID=361888994&spReportId=MzYxODg4OTk0S0